SHANNON SHOCKLEY: Open Payments
NPI 1881255511 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 43 payments from 16 companies in 2025. Trend: 2023 $218 · 2024 $436 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $190 |
| PFIZER INC. | 3 | $68 |
| ABBVIE INC. | 2 | $67 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Abbott Laboratories | 3 | $62 |
| Exact Sciences Corporation | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
Products named: Ozempic, QULIPTA, FREESTYLE LIBRE 3, Cologuard Collection Kit, NURTEC ODT, Rybelsus, Veozah, Wegovy.
Industry payments across GA — which companies pay providers there.
